| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | Australia | 2 | |
| #3 | Mexico | 2 | |
| #4 | United States | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Brazil | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology | |
| #4 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Enzymes | |
| #5 | Microorganisms | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Martín Gómez Laura | 3 |
| #2 | Aguado Fraile Elia | 3 |
| #3 | Conde Moreno Elisa | 3 |
| #4 | García Bermejo Laura | 3 |
| #5 | Gimenez Moyano Sara | 3 |
| #6 | Medina Heras Silvia | 2 |
| #7 | Alcázar González Alberto | 2 |
| #8 | José Luis Marco Contelles | 2 |
| #9 | Sainz De La Maza Cantero Susana | 2 |
| #10 | Alberto Alcázar González | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3663404A1 | Aptamers and the use thereof in the treatment of cancer | |
| EP3631463A1 | Method for monitoring and/or predicting the efficacy of treatment in a multiple sclerosis patient | |
| EP3500270A1 | Mir-127 agents for use in the treatment of renal fibrosis |